Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Osiris Therapeutics Inc confirms Lode Debrabandere as president and chief executive officer


Tuesday, 14 Jan 2014 08:00am EST 

Osiris Therapeutics Inc:Says its Board of Directors, at a Special Meeting held on Jan. 13, 2014, confirmed the nomination of Lode Debrabandere, as President and Chief Executive Officer of the company. 

Company Quote

14.29
0.14 +0.99%
29 Aug 2014